You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恩華藥業(002262.SZ):參股公司江蘇好欣晴定增引入量子躍動、復星等國內頂級投資機構
格隆匯 09-06 12:08

格隆匯9月6日丨恩華藥業(002262.SZ)公佈,公司參股公司江蘇好欣晴移動醫療科技有限公司(簡稱“江蘇好欣晴”)為了加快業務發展,進一步調整和優化股權架構,提升經營管理水平,擬引入新股東增加資本金。公司同意江蘇好欣晴此次增資方案並放棄優先認繳出資權。

江蘇好欣晴此次融資2億元,其中:新增註冊資本約人民幣1808.39萬元,其餘約1.82億元計入資本公積金。江蘇好欣晴此次融資分別由北京量子躍動科技有限公司、蘇州中新興富數智創業投資合夥企業(有限合夥)、寧波錦閩企業管理合夥企業(有限合夥)、杭州德佳誠譽投資合夥企業(有限合夥)、上海復星健康科技(集團)有限公司、蘇州通和毓承投資合夥企業(有限合夥)、景得(廣州)股權投資合夥企業(有限合夥)共同出資進行認購

江蘇好欣晴作為公司重點培育孵化的創新性企業,此次公司放棄對江蘇好欣晴增資優先認繳權,由量子躍動、中新興富、錦閩、德佳誠譽、復星、通和毓承、景得進行增資認購,一方面優化了江蘇好欣晴股權結構,另一方面滿足了江蘇好欣晴發展的資金需求,新增引進了量子躍動、中新興富、德佳誠譽、復星等國內頂級投資機構,有利於江蘇好欣晴引進高端人才,增強經營動力和企業活力,尤其重要的是能夠加快推進江蘇好欣晴上市進程,有利於提升江蘇好欣晴的平台價值及公司未來資本溢價收益,符合公司在移動醫療領域的戰略發展規劃。

此次融資、增資完成後,公司對江蘇好欣晴的出資比例將由28.2018%降至23.5015%,江蘇好欣晴仍為公司的參股公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account